Imexpharm

Imexpharm Fixed Asset Turnover

The Fixed Asset Turnover of Imexpharm (IMP.VN) as of Oct 27, 2026 is 1.65. In the previous year, Fixed Asset Turnover was 1.33 — a change of 24.46% (higher).

Fixed Asset Turnover

1.65

YoY

24.46%

Last updated:

Fixed Asset Turnover of Imexpharm is 2022 1.65 . Fixed Asset Turnover of Imexpharm was 2021 1.33 . It decreases by 24.46% higher compared to the previous year.

The Imexpharm Fixed Asset Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Fixed Asset Turnover
Date
Fixed Asset Turnover
Jan 1, 2015
4.65 VND
Jan 1, 2016
3.67 VND
Jan 1, 2017
1.88 VND
Jan 1, 2018
1.50 VND
Jan 1, 2019
1.56 VND
Jan 1, 2020
1.44 VND
Jan 1, 2021
1.33 VND
Jan 1, 2022
1.65 VND
The Imexpharm Fixed Asset Turnover history
YEARFixed Asset TurnoverYoY
1.65+24.46%
1.33-8.14%
1.44-7.80%
1.56+4.38%
1.50-20.37%
1.88-48.70%
3.67-21.12%
4.65-8.19%
5.07—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Fixed Asset Turnover of Imexpharm is 1.65 in 2022.

Fixed Asset Turnover of Imexpharm changed from 1.33 to 1.65, representing a 24.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Fixed Asset Turnover Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Fixed asset turnover measures revenue generated per unit of PP&E. Higher ratios indicate more efficient utilization of physical assets.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Fixed Asset Turnover's Imexpharm with sector peers and the industry average to assess whether it is attractive.

To evaluate Fixed Asset Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Fixed Asset Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Imexpharm

All Key Metrics — Imexpharm